Total Payments
$40,012
2024 Payments
$275.77
Companies
42
Transactions
744
Medicare Patients
5,599
Medicare Billing
$388,123
Payment Breakdown by Category
Other$27,195 (68.0%)
Food & Beverage$11,824 (29.6%)
Consulting$819.00 (2.0%)
Education$174.03 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,195 | 17 | 68.0% |
| Food and Beverage | $11,824 | 717 | 29.6% |
| Consulting Fee | $819.00 | 3 | 2.0% |
| Education | $174.03 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30,341 | 149 | $0 (2023) |
| GlaxoSmithKline, LLC. | $2,557 | 164 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,592 | 117 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,141 | 54 | $0 (2024) |
| Genentech USA, Inc. | $1,085 | 71 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $549.48 | 26 | $0 (2023) |
| Mylan Specialty L.P. | $441.45 | 26 | $0 (2024) |
| PFIZER INC. | $326.90 | 23 | $0 (2021) |
| Respiratory Technologies, Inc. | $277.35 | 16 | $0 (2017) |
| Philips Electronics North America Corporation | $247.88 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $275.77 | 13 | Inspire Medical Systems, Inc. ($51.95) |
| 2023 | $483.34 | 27 | GlaxoSmithKline, LLC. ($192.71) |
| 2022 | $165.18 | 8 | Novartis Pharmaceuticals Corporation ($65.61) |
| 2021 | $801.60 | 49 | GlaxoSmithKline, LLC. ($311.39) |
| 2020 | $1,308 | 76 | GlaxoSmithKline, LLC. ($363.61) |
| 2019 | $8,253 | 169 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,089) |
| 2018 | $10,751 | 207 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,576) |
| 2017 | $17,973 | 195 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15,308) |
All Payment Transactions
744 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $13.59 | General |
| Category: Elastography | ||||||
| 12/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/02/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Respiratory | ||||||
| 07/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Inflammation | ||||||
| 06/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Immunology | ||||||
| 09/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.53 | General |
| 09/15/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 829 | 1,288 | $245,859 | $77,634 |
| 2022 | 22 | 1,152 | 1,801 | $251,764 | $89,657 |
| 2021 | 21 | 2,966 | 3,839 | $457,439 | $171,810 |
| 2020 | 14 | 652 | 854 | $159,193 | $49,022 |
Total Patients
5,599
Total Services
7,782
Medicare Billing
$388,123
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 197 | $69,009 | $20,492 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 214 | $52,907 | $15,794 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $28,940 | $8,568 | 29.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $21,259 | $6,366 | 29.9% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 42 | 42 | $14,976 | $5,871 | 39.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 17 | 130 | $7,890 | $4,297 | 54.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 19 | 89 | $7,220 | $3,563 | 49.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 19 | 80 | $8,038 | $3,336 | 41.5% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 16 | 16 | $5,264 | $1,767 | 33.6% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 24 | 30 | $6,000 | $1,519 | 25.3% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 32 | 32 | $2,895 | $1,100 | 38.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 15 | 15 | $2,250 | $736.50 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 52 | $2,600 | $622.44 | 23.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 18 | 18 | $2,862 | $545.76 | 19.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 14 | 14 | $2,100 | $525.56 | 25.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 15 | 15 | $2,625 | $498.45 | 19.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,682 | $478.92 | 28.5% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 12 | 63 | $3,100 | $385.89 | 12.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 12 | $1,224 | $276.96 | 22.6% |
| G0454 | Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist | Office | 2023 | 30 | 38 | $570.00 | $254.10 | 44.6% |
| 86618 | Analysis for antibody borrelia burgdorferi (lyme disease bacteria) | Office | 2023 | 15 | 15 | $600.00 | $250.35 | 41.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 29 | $1,218 | $243.60 | 20.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 42 | $630.00 | $143.22 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 248 | $55,018 | $17,912 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 132 | $45,010 | $13,774 | 30.6% |
About Dr. Jasdeep Sidana, MD
Dr. Jasdeep Sidana, MD is a Pulmonary Disease healthcare provider based in Orange, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558482075.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jasdeep Sidana, MD has received a total of $40,012 in payments from pharmaceutical and medical device companies, with $275.77 received in 2024. These payments were reported across 744 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,195).
As a Medicare-enrolled provider, Sidana has provided services to 5,599 Medicare beneficiaries, totaling 7,782 services with total Medicare billing of $388,123. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Orange, CT
- Active Since 04/02/2007
- Last Updated 06/04/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558482075
Products in Payments
- OFEV (Drug) $12,844
- Xolair (Biological) $852.18
- NUCALA (Biological) $786.37
- TRELEGY ELLIPTA (Drug) $670.26
- BROVANA (Drug) $601.36
- LONHALA MAGNAIR (Drug) $560.06
- FASENRA (Drug) $521.70
- BREO (Drug) $471.42
- ANORO (Drug) $442.27
- STIOLTO RESPIMAT (Drug) $425.76
- XOLAIR (Biological) $390.82
- STIOLTO (Drug) $323.37
- Esbriet (Biological) $252.55
- Dymista (Drug) $227.17
- BEVESPI AEROSPHERE (Drug) $226.80
- SPIRIVA RESPIMAT (Drug) $206.66
- CHANTIX (Drug) $200.15
- ELIQUIS (Drug) $196.00
- SYMBICORT (Drug) $189.70
- UTIBRON NEOHALER (Drug) $175.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Orange
Bassam Yaghmour, M.d, M.D
Pulmonary Disease — Payments: $317,412
Pulmonary Disease $317,412
Dr. James Pearle, M.d, M.D
Pulmonary Disease — Payments: $133,562
Pulmonary Disease $133,562
Dr. Asad Javed, Medical Doctor, MEDICAL DOCTOR
Pulmonary Disease — Payments: $23,900
Pulmonary Disease $23,900
Jack Stewart, M.d, M.D
Pulmonary Disease — Payments: $20,129
Pulmonary Disease $20,129
Raymond Casciari, M.d, M.D
Pulmonary Disease — Payments: $17,121
Pulmonary Disease $17,121
Matthew Brenner, Md, MD
Pulmonary Disease — Payments: $16,169
Pulmonary Disease $16,169